← Leaderboards
Kenneth L Brigham
Vanderbilt University
$6,521,337
Attributed
$6,521,337
Total exposure
10
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $382.5K · FY2005–11$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$6,521,337 · 10
By mechanism
R01$2,506,960 · 2
P01$1,579,528 · 1
R42$1,059,627 · 2
T32$1,052,632 · 1
R41$322,590 · 3
M01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Ivan M Robbins$2,964,589
- Nancy Joan Brown$32,445,188
- Mark E Anderson$21,768,068
- Richard B Kim$2,161,767
- Barbara O Meyrick$1,755,864
Others in their field
Top investigators on “Liposomes”
- Katherine W Ferrara · Stanford University$21,313,923
- James C. Paulson · Scripps Research Institute$15,907,257
- David D McPherson · Northwestern University$13,361,624
- Michael B Zwick · Scripps Research Institute, The$13,172,478
- Gary Fujii · Molecular Express, Inc.$12,568,015
- Casey Koontz · Leidos, Inc.$11,293,734
Research focus
LiposomesInflammationGene ExpressionGene TherapyTranscription FactorEndotoxinsLung InjuryRespiratory EpitheliumCystic FibrosisCytokineTransfectionPulmonary EdemaAdult Respiratory Distress SyndromeProstaglandin EProstaglandin Endoperoxide SynthaseAlpha 1 AntitrypsinHuman Therapy EvaluationHuman SubjectBleomycinAnti-InflammatoryEndotoxemiaAnimalsBiochemicalAffect
Grant awards (26)
Pathogenesis of Liver-Dependent Acute Lung Injury$382,500
R01 · FY2011 · HL · contact PI
Pathogenesis of Liver-Dependent Acute Lung Injury$382,500
R01 · FY2010 · HL · contact PI
Pathogenesis of Liver-Dependent Acute Lung Injury$382,500
R01 · FY2009 · HL · contact PI
Pathogenesis of Liver-Dependent Acute Lung Injury$382,500
R01 · FY2008 · HL · contact PI
Pathogenesis of Liver-Dependent Acute Lung Injury$382,500
R01 · FY2007 · HL · contact PI
Liver Lung Interactions in Lung Inflammation$341,247
P01 · FY2006 · HL · contact PI
Liver Lung Interactions in Lung Inflammation$333,903
P01 · FY2005 · HL
Liver Lung Interactions in Lung Inflammation$326,580
P01 · FY2004 · HL
p20, Molecular Shortstop for Inflammatory Lung Diseases$284,688
R42 · FY2003 · HL
Role of Eicosanoids In Modulating Endotoxin Induced Live$278,671
P01 · FY2003 · HL
Role of Eicosanoids In Modulating Endotoxin Induced Live$299,127
P01 · FY2002 · HL
p20, Molecular Shortstop for Inflammatory Lung Diseases$274,939
R42 · FY2002 · HL
ALPHA 1 ANTITRYPSIN GENE IN NASAL EPITHELIUM--CYSTIC FIB$0
M01 · FY2002 · RR
PATHOPHYSIOLOGY OF THE PULMONARY MICROCIRCULATION$542,032
T32 · FY2001 · HL
LIVER-LUNG INTERACTIONS IN ACUTE LUNG INJURY$273,312
R01 · FY2001 · HL
A GENE-BASED THERAPEUTIC FOR PULMONARY HYPERTENSION$250,000
R42 · FY2001 · HL
Alpha-1 Antitrypsin Gene Therapy for Cystic Fibrosis$108,690
R41 · FY2001 · DK
In Vivo System - Screening Anti-Inflammatory Compounds$107,000
R41 · FY2001 · AI
ALPHA 1 ANTITRYPSIN GENE IN NASAL EPITHELIUM--CYSTIC FIB$0
M01 · FY2001 · RR
ALPHA 1 ANTITRYPSIN GENE IN NASAL EPITHELIUM--CYSTIC FIB$0
M01 · FY2001 · RR
ALPHA 1 ANTITRYPSIN GENE IN NASAL EPITHELIUM--CYSTIC FIB$0
M01 · FY2001 · RR
PATHOPHYSIOLOGY OF THE PULMONARY MICROCIRCULATION$510,600
T32 · FY2000 · HL
LIVER-LUNG INTERACTIONS IN ACUTE LUNG INJURY$321,148
R01 · FY2000 · HL
A GENE-BASED THERAPEUTIC FOR PULMONARY HYPERTENSION$250,000
R42 · FY2000 · HL
P20, 'MOLECULAR SHORTSTOP'FOR INFLAMATORY LUNG DISEASES$106,900
R41 · FY2000 · HL
ALPHA 1 ANTITRYPSIN GENE IN NASAL EPITHELIUM--CYSTIC FIB$0
M01 · FY2000 · RR